AngioDynamics falls on 2024 revenue outlook miss, wider Q4 loss

AngioDynamics

12/07/2023 12:33

**  Shares of medical technology company AngioDynamics Inc
 ANGO.O  down 2.2% at $9.7
    ** Co sees 2024 net sales in range of $328 mln to $333 mln,
below analysts' est. of $353 mln - Refinitiv data
    **Q4 adj. net loss was $2.4 mln, or $0.06 per share, vs adj.
net loss of $0.2 mln, or $0.00 per share, a year ago
    ** Cash and cash equivalents as of May 31 were $44.6 mln
    ** ANGO shares down 27.81% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))